This is a promotional website intended for UK healthcare professionals. If you are a member of the public, please click here.

Welcome to the Radioligand Therapy Hub.

Please confirm whether you are a UK healthcare professional or a member of the public. This website is not suitable for healthcare professionals outside of the United Kingdom.

No, I am a member of the public

Search Results

RLT Home
Introduction to RLT
Neuroendocrine tumours
Prostate cancer

Popular Search

prrt
masterclass
part
2022
2023

Coming soon

AAA-Lu177-UK-1862 | February 2023

Ask Speakers

Medical Information Request

Welcome to the Radioligand Therapy Hub.

Please confirm whether you are a UK healthcare professional or a member of public.

Yes, I am a UK healthcare professional

No, I am a member of the public

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]

Cookie Settings

Site directory

AAA-Lu177-UK-2264 | December 2023